Mechanisms for Targeted Delivery of Nanoparticles in Cancer

Author(s): Jaymes R. Beech, Soo J. Shin, Jeffrey A. Smith, Kimberly A. Kelly

Journal Name: Current Pharmaceutical Design

Volume 19 , Issue 37 , 2013

Become EABM
Become Reviewer
Call for Editor


With the evolution of the “omics” era, our molecular understanding of cancer has exponentially increased, leading to the development of the concept of personalized medicine. Nanoparticle technology has emerged as a way to combine cancer specific targeting with multifunctionality, such as imaging and therapy, leading to advantages over conventional small molecule based approaches. In this review, we discuss the targeting mechanisms of nanoparticles, which can be passive or active. The latter utilizes small molecules, aptamers, peptides, and antibodies as targeting moieties incorporated into the nanoparticle surface to deliver personalized therapy to patients.

Keywords: Nanoparticles, active targeting, passive targeting, cancer.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 26 September, 2013
Page: [6560 - 6574]
Pages: 15
DOI: 10.2174/1381612811319370002
Price: $65

Article Metrics

PDF: 35